FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2786019332> ?p ?o ?g. }

• W2786019332 endingPage "407" @default.
• W2786019332 startingPage "399" @default.
• W2786019332 abstract "Background: Few data are available on very long-term follow-up of pediatric multiple sclerosis (MS) patients treated with disease modifying treatments (DMTs). Objectives: To present a long-term follow-up of a cohort of Pediatric-MS patients starting injectable first-line agents. Methods: Data regarding treatments, annualized relapse rate (ARR), Expanded Disability Status Scale (EDSS) score, and serious adverse event were collected. Baseline characteristics were tested in multivariate analysis to identify predictors of disease evolution. Results: In total, 97 patients were followed for 12.5 ± 3.3 years. They started therapy at 13.9 ± 2.1 years, 88 with interferons and 9 with copaxone. During the whole follow-up, 82 patients changed therapy, switching to immunosuppressors/second-line treatment in 58% of cases. Compared to pre-treatment phase, the ARR was significantly reduced during the first treatment (from 3.2 ± 2.6 to 0.7 ± 1.5, p < 0.001), and it remained low during the whole follow-up (0.3 ± 0.2, p < 0.001). At last observation, 40% had disability worsening, but EDSS score remained <4 in 89%. One patient died at age of 23 years due to MS. One case of natalizumab-related progressive multifocal encephalopathy (PML) was recorded. Starting therapy before 12 years of age resulted in a better course of disease in multivariate analysis. Conclusion: Pediatric-MS patients benefited from interferons/copaxone, but the majority had to switch to more powerful drugs. Starting therapy before 12 years of age could lead to a more favorable outcome." @default.
• W2786019332 created "2018-02-23" @default.
• W2786019332 creator A5003803499 @default.
• W2786019332 creator A5003814961 @default.
• W2786019332 creator A5006120476 @default.
• W2786019332 creator A5008399548 @default.
• W2786019332 creator A5008670972 @default.
• W2786019332 creator A5011959155 @default.
• W2786019332 creator A5017734894 @default.
• W2786019332 creator A5018024307 @default.
• W2786019332 creator A5023350680 @default.
• W2786019332 creator A5031869995 @default.
• W2786019332 creator A5034169069 @default.
• W2786019332 creator A5036405171 @default.
• W2786019332 creator A5045081565 @default.
• W2786019332 creator A5046530867 @default.
• W2786019332 creator A5046558303 @default.
• W2786019332 creator A5048070907 @default.
• W2786019332 creator A5050626771 @default.
• W2786019332 creator A5054428701 @default.
• W2786019332 creator A5062156098 @default.
• W2786019332 creator A5066578359 @default.
• W2786019332 creator A5067125369 @default.
• W2786019332 creator A5067412910 @default.
• W2786019332 creator A5071409158 @default.
• W2786019332 creator A5075124568 @default.
• W2786019332 creator A5081298128 @default.
• W2786019332 creator A5091204142 @default.
• W2786019332 date "2018-01-24" @default.
• W2786019332 modified "2023-10-12" @default.
• W2786019332 title "Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study" @default.
• W2786019332 cites W1910618472 @default.
• W2786019332 cites W1971452447 @default.
• W2786019332 cites W1975434298 @default.
• W2786019332 cites W1983148737 @default.
• W2786019332 cites W1987389316 @default.
• W2786019332 cites W2000949921 @default.
• W2786019332 cites W2002726682 @default.
• W2786019332 cites W2004913798 @default.
• W2786019332 cites W2012152988 @default.
• W2786019332 cites W2025358672 @default.
• W2786019332 cites W2036863084 @default.
• W2786019332 cites W2041135783 @default.
• W2786019332 cites W2060197077 @default.
• W2786019332 cites W2062835959 @default.
• W2786019332 cites W2075512998 @default.
• W2786019332 cites W2082301316 @default.
• W2786019332 cites W2087353379 @default.
• W2786019332 cites W2090207085 @default.
• W2786019332 cites W2091664685 @default.
• W2786019332 cites W2095300907 @default.
• W2786019332 cites W2099893652 @default.
• W2786019332 cites W2106695839 @default.
• W2786019332 cites W2119663920 @default.
• W2786019332 cites W2132063764 @default.
• W2786019332 cites W2139535317 @default.
• W2786019332 cites W2149626428 @default.
• W2786019332 cites W2152959293 @default.
• W2786019332 cites W2266233634 @default.
• W2786019332 cites W2410602374 @default.
• W2786019332 cites W2417250624 @default.
• W2786019332 cites W2514055248 @default.
• W2786019332 cites W2579084024 @default.
• W2786019332 cites W4240233136 @default.
• W2786019332 cites W603119456 @default.
• W2786019332 doi "https://doi.org/10.1177/1352458518754364" @default.
• W2786019332 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29363396" @default.
• W2786019332 hasPublicationYear "2018" @default.
• W2786019332 type Work @default.
• W2786019332 sameAs 2786019332 @default.
• W2786019332 citedByCount "33" @default.
• W2786019332 countsByYear W27860193322018 @default.
• W2786019332 countsByYear W27860193322019 @default.
• W2786019332 countsByYear W27860193322020 @default.
• W2786019332 countsByYear W27860193322021 @default.
• W2786019332 countsByYear W27860193322022 @default.
• W2786019332 countsByYear W27860193322023 @default.
• W2786019332 crossrefType "journal-article" @default.
• W2786019332 hasAuthorship W2786019332A5003803499 @default.
• W2786019332 hasAuthorship W2786019332A5003814961 @default.
• W2786019332 hasAuthorship W2786019332A5006120476 @default.
• W2786019332 hasAuthorship W2786019332A5008399548 @default.
• W2786019332 hasAuthorship W2786019332A5008670972 @default.
• W2786019332 hasAuthorship W2786019332A5011959155 @default.
• W2786019332 hasAuthorship W2786019332A5017734894 @default.
• W2786019332 hasAuthorship W2786019332A5018024307 @default.
• W2786019332 hasAuthorship W2786019332A5023350680 @default.
• W2786019332 hasAuthorship W2786019332A5031869995 @default.
• W2786019332 hasAuthorship W2786019332A5034169069 @default.
• W2786019332 hasAuthorship W2786019332A5036405171 @default.
• W2786019332 hasAuthorship W2786019332A5045081565 @default.
• W2786019332 hasAuthorship W2786019332A5046530867 @default.
• W2786019332 hasAuthorship W2786019332A5046558303 @default.
• W2786019332 hasAuthorship W2786019332A5048070907 @default.
• W2786019332 hasAuthorship W2786019332A5050626771 @default.
• W2786019332 hasAuthorship W2786019332A5054428701 @default.
• W2786019332 hasAuthorship W2786019332A5062156098 @default.
• W2786019332 hasAuthorship W2786019332A5066578359 @default.

• next